Container Closure Integrity

Container Closure Integrity (CCI) testing confirms the container closure system capability to provide required protection to the drug product and to demonstrate the maintenance of product sterility through commercial shelf-life stability.

Xepics has chosen to offer deterministic and non-destructive leak test method technologies in order to meet the parenteral packaging needs of our clients and the current regulatory requirements.

A deterministic method operates based on predictable physic/chemical phenomena and is therefore ideal for conclusive integrity evaluation; a non-destructive methods enables 100% testing, both online and offline, allowing for comprehensive analysis of defects and their root causes.

error: Content is protected !!